首页> 外文期刊>International Journal of Pharmaceutics >Nanoparticles formed from PNIPAM-g-PEO copolymers in the presence of indomethacin.
【24h】

Nanoparticles formed from PNIPAM-g-PEO copolymers in the presence of indomethacin.

机译:在吲哚美辛存在下由PNIPAM-g-PEO共聚物形成的纳米颗粒。

获取原文
获取原文并翻译 | 示例
       

摘要

Biocompatible double-hydrophilic PNIPAM-g-PEO copolymers containing 0.3-3.2 mol% PEO grafts were synthesized and utilized to prepare indomethacin (IMC)-loaded core-shell nanoparticles by dialysis and nanoprecipitation methods. IMC loading was conducted at room temperature using the organic solvents ethanol and DMF, which induced phase separation in the copolymers aqueous solutions due to the cononsolvency of PNIPAM. In ethanol-water solutions, the cononsolvency-induced phase separation of the copolymers promoted effective drug incorporation into the formed micellar structures. In DMF-water system, the formation of the nanoparticles did not correspond to the cononsolvent region of PNIPAM-g-PEO. In this case, hydrophobic interactions between PNIPAM and IMC allowed the copolymer self-association and drug loading. Irrespective of the solvents or preparation methods applied, the drug loading content (DLC) depended on the drug-to-copolymer feed weight ratio. DLC was relatively low at the 0.5:1 ratio but it significantly increased at the ratios of 0.75:1 and 1:1 (DLC approximately 90%). The particle size was strongly affected by the different mechanisms of nanoparticles formation. The nanoprecipitation from ethanol produced significantly smaller particles (<150 nm) with narrow size distribution than the dialysis from DMF. The velocity of indomethacin release from the nanoparticles was influenced by the amount of encapsulated drug, the process being faster at lower DLC.
机译:合成了包含0.3-3.2 mol%PEO接枝物的生物相容性双亲水PNIPAM-g-PEO共聚物,并通过透析和纳米沉淀法将其用于制备负载吲哚美辛(IMC)的核壳纳米粒子。 IMC加载是在室温下使用有机溶剂乙醇和DMF进行的,由于PNIPAM的共溶性,它们在共聚物水溶液中引起相分离。在乙醇水溶液中,共聚物的共溶剂诱导相分离促进了药物有效结合到形成的胶束结构中。在DMF-水系统中,纳米颗粒的形成与PNIPAM-g-PEO的共溶剂区域不对应。在这种情况下,PNIPAM和IMC之间的疏水相互作用使共聚物具有自缔合和载药量。无论使用何种溶剂或制备方法,载药量(DLC)均取决于药物与共聚物的进料重量比。 DLC在0.5:1的比例下相对较低,但在0.75:1和1:1的比例下显着增加(DLC约为90%)。粒径受纳米颗粒形成的不同机制的强烈影响。与DMF透析相比,乙醇的纳米沉淀产生了明显更小的颗粒(<150 nm),粒径分布窄。吲哚美辛从纳米颗粒中释放的速度受封装药物的量的影响,该过程在较低的DLC时更快。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号